Related Experiment Video
Updated: Aug 5, 2025

09:49
In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
Published on: November 20, 2018
18.8K
FTD-tau S320F mutation stabilizes local structure and allosterically promotes amyloid motif-dependent aggregation
Dailu Chen1,2, Sofia Bali1,2, Ruhar Singh2
1Molecular Biophysics Graduate Program, University of Texas Southwestern Medical Center, Dallas, Texas, 75390, USA.
Nature Communications
|March 24, 2023
Summary
Frontotemporal dementia with abnormal tau (FTD-tau) mutations drive protein aggregation. A specific mutation (S320F) stabilizes hydrophobic clusters, exposing aggregation-prone motifs and advancing neurodegenerative disease research.
Area of Science:
- Neuroscience
- Biochemistry
- Structural Biology
Background:
- Amyloid deposition of microtubule-associated protein tau is linked to neurodegenerative diseases.
- Missense mutations in tau, observed in frontotemporal dementia with abnormal tau (FTD-tau), increase its aggregation propensity.
Purpose of the Study:
- To elucidate the structural mechanism by which the FTD-tau S320F mutation promotes spontaneous tau aggregation.
- To identify strategies for controlling tau aggregation pathways.
Main Methods:
- Integration of in vitro, in silico (computational), and cellular experiments.
- Structural analysis of tau mutations and their effects on aggregation motifs.
- Computational engineering of tau sequences to optimize aggregation propensity.
Main Results:
- The S320F mutation stabilizes a local hydrophobic cluster, allosterically exposing the 306VQIVYK311 amyloid motif.
- A suppressor mutation was identified that destabilizes S320F-induced hydrophobic clustering, reversing the aggregation phenotype.
- Computationally engineered tau sequences demonstrated optimized nonpolar clusters around S320, leading to spontaneous aggregation.
Conclusions:
- A regulatory mechanism for tau aggregation involves balancing local nonpolar contacts with long-range interactions that sequester amyloid motifs.
- Understanding this mechanism could enable the design of reagents targeting disease-specific tau conformations for therapeutic intervention.

